Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 843865

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel

Santos, Raul D.; ....Reiner, Željko; ....Yamashita, Shizuya
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel // Lancet Diabetes & Endocrinology, 4 (2016), 10; 850-861 doi:10.1016/S2213-8587(16)30041-9 (međunarodna recenzija, pregledni rad, znanstveni)

CROSBI ID: 843865 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel

Autori
Santos, Raul D. ; ....Reiner, Željko ; ....Yamashita, Shizuya

Izvornik
Lancet Diabetes & Endocrinology (2213-8587) 4 (2016), 10; 850-861

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Familial hypercholesterolaemia (FH) ; treatment ; PCSK9 inhibitors ; mipomersen ; lomitapide

Sažetak
Everyone with familial hypercholesterolaemia has an increased lifetime risk fir atherosclerotic cardiovascular disease, but a group with enhanced risk can be identified. In addition to patients with symptomatic atherosclerotic cardiovascular disease, this group included individuals with the highest levels lf LDL cholesterol, those with advanced subclinical coronary atherosclerosis, and people with additional risk factors for atherosclerotic cardiovascular disease.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA

Projekti:
108-1080134-0121 - Percepcija i prevencija čimbenika rizika za aterosklerozu u Hrvatskoj (Reiner, Željko, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Željko Reiner (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Santos, Raul D.; ....Reiner, Željko; ....Yamashita, Shizuya
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel // Lancet Diabetes & Endocrinology, 4 (2016), 10; 850-861 doi:10.1016/S2213-8587(16)30041-9 (međunarodna recenzija, pregledni rad, znanstveni)
Santos, R., ....Reiner, Ž. & ....Yamashita, S. (2016) Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel. Lancet Diabetes & Endocrinology, 4 (10), 850-861 doi:10.1016/S2213-8587(16)30041-9.
@article{article, author = {Santos, Raul D. and ....Reiner, \v{Z}eljko and ....Yamashita, Shizuya}, year = {2016}, pages = {850-861}, DOI = {10.1016/S2213-8587(16)30041-9}, keywords = {Familial hypercholesterolaemia (FH), treatment, PCSK9 inhibitors, mipomersen, lomitapide}, journal = {Lancet Diabetes and Endocrinology}, doi = {10.1016/S2213-8587(16)30041-9}, volume = {4}, number = {10}, issn = {2213-8587}, title = {Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel}, keyword = {Familial hypercholesterolaemia (FH), treatment, PCSK9 inhibitors, mipomersen, lomitapide} }
@article{article, author = {Santos, Raul D. and ....Reiner, \v{Z}eljko and ....Yamashita, Shizuya}, year = {2016}, pages = {850-861}, DOI = {10.1016/S2213-8587(16)30041-9}, keywords = {Familial hypercholesterolaemia (FH), treatment, PCSK9 inhibitors, mipomersen, lomitapide}, journal = {Lancet Diabetes and Endocrinology}, doi = {10.1016/S2213-8587(16)30041-9}, volume = {4}, number = {10}, issn = {2213-8587}, title = {Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel}, keyword = {Familial hypercholesterolaemia (FH), treatment, PCSK9 inhibitors, mipomersen, lomitapide} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.